Literature DB >> 28296524

Challenges to Opioid Treatment Programs After Hurricane Sandy: Patient and Provider Perspectives on Preparation, Impact, and Recovery.

Harlan Matusow1, Ellen Benoit1, Luther Elliott1, Eloise Dunlap1, Andrew Rosenblum1.   

Abstract

Over 300,000 patients with an opioid use disorder (OUD) receive methadone maintenance therapy from opioid treatment programs (OTPs) in the United States. Large numbers of these attend OTPs located in New York and New Jersey, areas (largely but not exclusively coastal) impacted by Hurricane Sandy (Sandy) on October 29th, 2012. Disruption of methadone dispensing and other services can have severe consequences to patients (and treatment seekers) such as relapse, dropping out of treatment and resumption or increase in HIV/HCV injection risk behaviors. To facilitate OTP preparedness and response, we developed recommendations for OTPs for future emergencies. Using both qualitative and quantitative measures, we obtained data from OTP directors, staff, patients and out-of-treatment persons to learn how OTPs prepared for the impending hurricane, whether recovery efforts were successful, and what impact the hurricane has had. We observed a wide range of preparation and recovery efforts among participating programs. Director, staff, and patient perspectives on programs' responses and storm impact often differed. Triangulated data suggest that program responses were adequate for a majority of patients. For a sizeable minority of patients, program responses were very successful; for at least 20% of the clinics, program planning and responses were inadequate to meet the needs of patients. Among the recommendations made for sustaining continuity of care in future emergencies are: a focus on improving communication, procuring transportation, guest dosing, and take home provisions.

Entities:  

Keywords:  Disaster preparedness; Hurricane Sandy; OTPs; buprenorphine; methadone; opioid treatment; treatment access

Mesh:

Substances:

Year:  2017        PMID: 28296524     DOI: 10.1080/10826084.2016.1267225

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN: 1082-6084            Impact factor:   2.164


  11 in total

1.  Characterizing Self-Reports of Self-Identified Patient Experiences with Methadone Maintenance Treatment on an Online Community during COVID-19.

Authors:  Alicia L Nobles; Derek C Johnson; Eric C Leas; David Goodman-Meza; María Luisa Zúñiga; Douglas Ziedonis; Steffanie A Strathdee; John W Ayers
Journal:  Subst Use Misuse       Date:  2021-09-05       Impact factor: 2.362

2.  Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.

Authors:  Gerald Cochran; Julie Bruneau; Nicholas Cox; Adam J Gordon
Journal:  Subst Abus       Date:  2020       Impact factor: 3.716

3.  Intermittent theta burst transcranial magnetic stimulation for methamphetamine addiction: A randomized clinical trial.

Authors:  Hang Su; Tianzhen Chen; Haifeng Jiang; Na Zhong; Jiang Du; Ke Xiao; Ding Xu; Weidong Song; Min Zhao
Journal:  Eur Neuropsychopharmacol       Date:  2020-01-02       Impact factor: 4.600

4.  Response to coronavirus 2019 in Veterans Health Administration facilities participating in an implementation initiative to enhance access to medication for opioid use disorder.

Authors:  Allison M Gustavson; Adam J Gordon; Marie E Kenny; Haley McHenry; Julie Gronek; Princess E Ackland; Hildi J Hagedorn
Journal:  Subst Abus       Date:  2020-09-16       Impact factor: 3.716

5.  "How will I get my next week's script?" Reactions of Reddit opioid forum users to changes in treatment access in the early months of the coronavirus pandemic.

Authors:  Noa Krawczyk; Amanda M Bunting; David Frank; Joshua Arshonsky; Yuanqi Gu; Samuel R Friedman; Marie A Bragg
Journal:  Int J Drug Policy       Date:  2021-02-06

6.  Challenges of methadone maintenance treatment during the COVID-19 epidemic in China: Policy and service recommendations.

Authors:  Haifeng Jiang; Hang Su; Changchun Zhang; Xuebing Liu; Ruihua Li; Na Zhong; Min Zhao
Journal:  Eur Neuropsychopharmacol       Date:  2020-04-13       Impact factor: 4.600

Review 7.  A rapid review of the impacts of "Big Events" on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19.

Authors:  Camille Zolopa; Stine Hoj; Julie Bruneau; Julie-Soleil Meeson; Nanor Minoyan; Marie-France Raynault; Iuliia Makarenko; Sarah Larney
Journal:  Int J Drug Policy       Date:  2021-01-20

8.  Clinician perspectives on methadone service delivery and the use of telemedicine during the COVID-19 pandemic: A qualitative study.

Authors:  Sarah B Hunter; Alex R Dopp; Allison J Ober; Lori Uscher-Pines
Journal:  J Subst Abuse Treat       Date:  2021-01-13

9.  The COVID-19 pandemic and the health of people who use illicit opioids in New York City, the first 12 months.

Authors:  Alex S Bennett; Tarlise Townsend; Luther Elliott
Journal:  Int J Drug Policy       Date:  2021-12-01

10.  Opioid treatment program safety measures during the COVID-19 pandemic: a statewide survey.

Authors:  Sachini Bandara; Hannah Maniates; Eric Hulsey; Jennifer S Smith; Ellen DiDomenico; Elizabeth A Stuart; Brendan Saloner; Noa Krawczyk
Journal:  BMC Health Serv Res       Date:  2022-03-30       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.